By John Lee.
The Ambassador of Republic of Iraq in London, Mr. Muhammad Jaafar Al-Sadr, chaired a meeting with representatives of the British pharmaceutical group, AstraZeneca, which is a leading company in Coronavirus vaccine in cooperation with the University of Oxford in Britain, through video conference.
The meeting discussed the possibility of Iraq obtaining adequate doses of the vaccine produced by the company that are being developed, in addition to the possibility of the early launch of the vaccine.
During the meeting, the Ambassador thanked the group for the efforts made by the company to produce the vaccine, which would be a scientific achievement to protect humanity from the risks of infection with the Coronavirus, stressing Iraq’s desire to obtain the vaccine after its production.
While the company has expressed its readiness to supply Iraq with the vaccine after the last experimental stages which will be ready by the end of this year, especially after making sure of its safety, effectiveness and compliance with international health standards. The company is conducting clinical trials of the vaccine in several regions of the world, including the United States, Russia and a number of Latin American countries.
This meeting comes within a series of meetings held by the embassy with the company and other pharmaceutical companies in order to ensure that Iraq receives the vaccine in the start of its production.
(Source: Iraqi Ministry of Foreign Affairs)
The post Iraq discusses sourcing Covid Vaccine with AstraZeneca first appeared on Iraq Business News.